Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients

SIMPLE SUMMARY: Circulating tumor cells (CTCs) originating from cutaneous melanoma patients have been studied for several decades as surrogates for real-time clinical status and disease outcomes. Here, we will review clinical studies from the last 15 years that assessed CTCs and disease outcomes for...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Yoshiaki, Bustos, Matias A., Gross, Rebecca, Hoon, Dave S. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870206/
https://www.ncbi.nlm.nih.gov/pubmed/35205608
http://dx.doi.org/10.3390/cancers14040859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870206/
https://www.ncbi.nlm.nih.gov/pubmed/35205608
http://dx.doi.org/10.3390/cancers14040859

Ejemplares similares